These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 28865463)

  • 1. Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis.
    Nakajima M; Yamamoto N; Hayashi K; Karube M; Ebner DK; Takahashi W; Anzai M; Tsushima K; Tada Y; Tatsumi K; Miyamoto T; Tsuji H; Fujisawa T; Kamada T
    Radiat Oncol; 2017 Sep; 12(1):144. PubMed ID: 28865463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
    Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
    Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical results of carbon-ion radiotherapy for stage I non-small cell lung cancer with concomitant interstitial lung disease: a Japanese national registry study (J-CROS-LUNG).
    Okano N; Suefuji H; Nakajima M; Tokumaru S; Kubo N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shioyama Y
    J Radiat Res; 2023 Jun; 64(Supplement_1):i2-i7. PubMed ID: 37036751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis.
    Yamaguchi S; Ohguri T; Ide S; Aoki T; Imada H; Yahara K; Narisada H; Korogi Y
    Lung Cancer; 2013 Nov; 82(2):260-5. PubMed ID: 24054547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer.
    Ueki N; Matsuo Y; Togashi Y; Kubo T; Shibuya K; Iizuka Y; Mizowaki T; Togashi K; Mishima M; Hiraoka M
    J Thorac Oncol; 2015 Jan; 10(1):116-25. PubMed ID: 25376512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and risk factors for interstitial lung disease spreading in low-dose irradiated areas after definitive radiotherapy with or without durvalumab consolidation therapy for patients with non-small cell lung cancer.
    Sakagami M; Inokuchi H; Mukumoto N; Itoyama H; Hamaura N; Yamagishi M; Mukumoto N; Matsuda S; Kabata D; Shibuya K
    Radiat Oncol; 2023 May; 18(1):87. PubMed ID: 37217919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Thoracic Radiotherapy an Absolute Contraindication for Treatment of Lung Cancer Patients With Interstitial Lung Disease? A Systematic Review.
    Saha A; Dickinson P; Shrimali RK; Salem A; Agarwal S
    Clin Oncol (R Coll Radiol); 2022 Dec; 34(12):e493-e504. PubMed ID: 35168842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: A Japanese national registry study (J-CROS-LUNG).
    Kubo N; Suefuji H; Nakajima M; Tokumaru S; Okano N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shioyama Y
    Radiother Oncol; 2023 Jun; 183():109640. PubMed ID: 36990390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Radiation Pneumonitis History Before Nivolumab with Onset of Interstitial Lung Disease and Progression-free Survival of Patients with Pre-treated Advanced Non-small Cell Lung Cancer.
    Tamiya A; Tamiya M; Nakahama K; Taniguchi Y; Shiroyama T; Isa SI; Inoue T; Okishio K; Nishino K; Kumagai T; Suzuki H; Hirashima T; Imamura F; Atagi S
    Anticancer Res; 2017 Sep; 37(9):5199-5205. PubMed ID: 28870955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC).
    Takahashi W; Nakajima M; Yamamoto N; Yamashita H; Nakagawa K; Miyamoto T; Tsuji H; Kamada T; Fujisawa T
    Cancer; 2015 Apr; 121(8):1321-7. PubMed ID: 25641119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy - a single-centre experience.
    Henkenberens C; Janssen S; Lavae-Mokhtari M; Leni K; Meyer A; Christiansen H; Bremer M; Dickgreber N
    Radiat Oncol; 2016 Feb; 11():12. PubMed ID: 26830686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy.
    Li F; Liu H; Wu H; Liang S; Xu Y
    Radiat Oncol; 2021 Apr; 16(1):70. PubMed ID: 33849579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nationwide survey of radiation therapy in Japan for lung cancer complicated with interstitial lung disease.
    Hagiwara Y; Nakayama Y; Kudo S; Hayakawa T; Nakamura N; Kitamoto Y; Takahashi S; Tsujino K; Kubo N; Tamaki Y; Nagata Y;
    J Radiat Res; 2020 Jul; 61(4):563-574. PubMed ID: 32363376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT).
    Glick D; Lyen S; Kandel S; Shapera S; Le LW; Lindsay P; Wong O; Bezjak A; Brade A; Cho BCJ; Hope A; Sun A; Giuliani M
    Clin Lung Cancer; 2018 Mar; 19(2):e219-e226. PubMed ID: 29066051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease.
    Saito T; Ohnishi K; Ishikawa H; Nakamura M; Hoshiai S; Numajiri H; Murofushi KN; Mizumoto M; Okumura T; Sakurai H
    Anticancer Res; 2021 Nov; 41(11):5635-5642. PubMed ID: 34732436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial.
    Palma DA; Chen H; Bahig H; Gaede S; Harrow S; Laba JM; Qu XM; Rodrigues GB; Yaremko BP; Yu E; Louie AV; Dhaliwal I; Ryerson CJ
    BMC Cancer; 2019 Dec; 19(1):1206. PubMed ID: 31829203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease.
    Bahig H; Filion E; Vu T; Chalaoui J; Lambert L; Roberge D; Gagnon M; Fortin B; Béliveau-Nadeau D; Mathieu D; Campeau MP
    Pract Radiat Oncol; 2016; 6(5):367-374. PubMed ID: 27068780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Carbon-ion Radiotherapy Alone for Stage III Non-small Cell Lung Cancer.
    Anzai M; Yamamoto N; Hayashi K; Nakajima M; Nomoto A; Ogawa K; Tsuji H
    Anticancer Res; 2020 Jan; 40(1):379-386. PubMed ID: 31892590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon-ion radiotherapy for patients with advanced stage non-small-cell lung cancer at multicenters.
    Karube M; Yamamoto N; Shioyama Y; Saito J; Matsunobu A; Okimoto T; Ohno T; Tsuji H; Nakano T; Kamada T
    J Radiat Res; 2017 Sep; 58(5):761-764. PubMed ID: 28992088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.